MiniLap Vs Standard Laparoscopy in Prophylactic Bilateral Salpingo-oophorectomy in BRCA-Mutated Patients
- Conditions
- BRCA Mutation
- Registration Number
- NCT06831747
- Brief Summary
The study hypothesis is that surgical treatment performed with MiniLap results in reduced postoperative pain in a population of patients undergoing prophylactic laparoscopic adnexal surgery. The primary objectives are to assess differences in operative duration, intraoperative blood loss, and postoperative complications in patients undergoing bilateral laparoscopic adnexectomy performed with standard laparoscopy versus MiniLap. The secondary objectives of this study are to compare postoperative pain and patient satisfaction with aesthetic outcomes.
Patients with BRCA 1/2 mutations undergoing prophylactic surgery will be assigned to either MiniLap or standard laparoscopic treatment based on randomization. Subsequently, the necessary study data will be collected using the hospital's electronic management system and medical records.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 80
- Patients undergoing prophylactic bilateral adnexectomy via laparoscopic surgery.
- Patients with a germline mutation in the BRCA1/2 gene.
- Patients who underwent additional surgery during the adnexectomy procedure.
- Patients in whom an intraoperative frozen section is required.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Perioperative outcomes: operative time (minutes), intraoperative blood loss (mL), postoperative complications (clavien dindo classification) From enrollment to 30 days postoperatively The primary objectives are to assess differences in:
operative time (minutes), intraoperative blood loss (mL), postoperative complications (clavien dindo classification) in patients undergoing bilateral laparoscopic adnexectomy performed with standard laparoscopy versus MiniLap.
- Secondary Outcome Measures
Name Time Method Pain (Visual Analog Score) From enrollment to 2 days postoperatively. The secondary objective of this study is to compare postoperative pain (VAS 0-10; higher scores mean worse)
Cosmetic results (Visual Analog Score) From enrollment to 60 days postoperatively. The secondary objective of this study is to compare patient satisfaction with aesthetic outcomes using a VAS scale (0-10, with higher scores indicating greater satisfaction).
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Department of Maternal and Child Health, Obstetrics and Gynecology Clinic, University Hospital of Udine
🇮🇹Udine, Italy
Department of Maternal and Child Health, Obstetrics and Gynecology Clinic, University Hospital of Udine🇮🇹Udine, ItalyStefano RestainoContact+390432559653stefano.restaino@asufc.sanita.fvg.it